Edifice Health
EDIFICE Health is a biotechnology company focused on tackling systemic chronic inflammation, which is identified as the root cause of age-related diseases. Leveraging a decade of NIH-funded research from Stanford University's 1,000 Immunomes Project, Edifice Health has developed the proprietary Inflammatory Age® test. This test utilizes advanced 'omics' platforms and artificial intelligence to provide a novel biomarker composite scoring system for measuring an individual's inflammatory and immune health. The company partners with clinics and physicians to offer these tests for early disease detection and prevention, aiming to help patients proactively manage chronic inflammation for improved health and longevity. Their scientific advisory board comprises experts in immunology and age-related diseases.
Edifice Health
EDIFICE Health is a biotechnology company focused on tackling systemic chronic inflammation, which is identified as the root cause of age-related diseases. Leveraging a decade of NIH-funded research from Stanford University's 1,000 Immunomes Project, Edifice Health has developed the proprietary Inflammatory Age® test. This test utilizes advanced 'omics' platforms and artificial intelligence to provide a novel biomarker composite scoring system for measuring an individual's inflammatory and immune health. The company partners with clinics and physicians to offer these tests for early disease detection and prevention, aiming to help patients proactively manage chronic inflammation for improved health and longevity. Their scientific advisory board comprises experts in immunology and age-related diseases.